Yakima Z.R. Phillips

ORCID: 0000-0003-3199-4389
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 Clinical Research Studies
  • COVID-19 epidemiological studies
  • SARS-CoV-2 detection and testing
  • Hepatitis B Virus Studies
  • Global Maternal and Child Health
  • Viral Infections and Vectors
  • Respiratory viral infections research
  • Mosquito-borne diseases and control
  • Hepatitis C virus research
  • HIV/AIDS drug development and treatment

University of the West Indies System
2020-2023

University of Padua
2022

University of the West
2022

University of the West Indies
2021-2022

South Dakota State University
2022

University of Technology, Jamaica
2022

Global Virus Network
2022

University of Bristol
2022

University College London
2022

Fundação Oswaldo Cruz
2022

Abstract To determine the extent of exposure to Zika virus (ZIKV) and chikungunya (CHIKV) in Jamaica, we collected serum from 584 pregnant women during 2017–2019. We found that 15.6% had antibodies against ZIKV 83.6% CHIKV. These results indicate potential recirculation but not CHIKV near future.

10.3201/eid2802.211849 article EN cc-by Emerging infectious diseases 2022-01-13

A cross-sectional SARS-CoV-2 serosurvey was conducted after the Omicron surge in Jamaica using 1,540 samples collected during March – May 2022 from persons attending antenatal, STI and non-communicable diseases clinics Kingston, Jamaica. spike receptor binding domain (RBD) and/or nucleocapsid IgG antibodies were detected for 88.4% of study population, with 77.0% showing evidence previous infection. Of previously infected COVID-19 vaccination, 9.6% negative RBD IgG, most which unvaccinated...

10.1016/j.jcvp.2022.100124 article EN cc-by Journal of Clinical Virology Plus 2022-11-01

The performance of the Roche Elecsys® Anti-SARS-CoV-2, Abbott Architect SARS-CoV-2 IgM, IgG, Euroimmun IgA, IgG ELISA, and Trillium IgG/IgM rapid assays was evaluated in Jamaica.

10.1016/j.ijid.2021.02.059 article EN cc-by-nc-nd International Journal of Infectious Diseases 2021-02-19

Abstract The performance of the Roche Elecsys ® Anti-SARS-CoV-2, Abbott Architect SARS-CoV-2 IgG, Euroimmun IgA, IgG ELISA, and Trillium IgG/IgM rapid assays was evaluated in Jamaica, largest country English-speaking Caribbean. Diagnostic sensitivities were assessed by testing serum samples from PCR-confirmed persons. Serum collected ≥14 days after onset symptoms, or an initial RT-PCR positive test for asymptomatics, showed diagnostic ranging 67.9-75.0% when including all possible disease...

10.1101/2020.09.27.20202655 preprint EN medRxiv (Cold Spring Harbor Laboratory) 2020-09-29

A cross-sectional SARS-CoV-2 serosurvey was conducted after the Omicron surge in Jamaica using 1,540 samples collected during March â€" May 2022 from persons attending antenatal, STI and non-communicable diseases clinics Kingston, Jamaica. spike receptor binding domain (RBD) and/or nucleocapsid IgG antibodies were detected for 88.4% of study population, with 77.0% showing evidence previous infection. Of previously infected COVID-19 vaccination, 9.6% negative RBD IgG, most which unvaccinated...

10.1101/2022.09.20.22280173 preprint EN cc-by-nc-nd medRxiv (Cold Spring Harbor Laboratory) 2022-09-21
Coming Soon ...